HER2 as a Biomarker in Metastatic Colorectal Cancer
An expert on colorectal cancer discusses the relationship between HER2 status and treatment selection and response.
Post Conference Perspectives Metastatic Colorectal Cancer Metastatic Colorectal Colorectal Cancer Her2 Amplification Antibody Drug Conjugates
Source: onclive.com